177 related articles for article (PubMed ID: 15214951)
1. Clinical pharmacology of clemastine in healthy dogs.
Hansson H; Bergvall K; Bondesson U; Hedeland M; Törneke K
Vet Dermatol; 2004 Jun; 15(3):152-8. PubMed ID: 15214951
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of clemastine in healthy horses.
Törneke K; Ingvast-Larsson C; Pettersson K; Bergvall K; Hedeland M; Bondesson U; Broström H
J Vet Pharmacol Ther; 2003 Apr; 26(2):151-7. PubMed ID: 12667185
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
Bizikova P; Papich MG; Olivry T
Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.
Schran HF; Petryk L; Chang CT; O'Connor R; Gelbert MB
J Clin Pharmacol; 1996 Oct; 36(10):911-22. PubMed ID: 8930778
[TBL] [Abstract][Full Text] [Related]
5. Gaschromatography of clemastine. A study of plasma kinetics and biological effect.
Tham R; Norlander B; Hägermark O; Fransson L
Arzneimittelforschung; 1978; 28(6):1017-20. PubMed ID: 35180
[TBL] [Abstract][Full Text] [Related]
6. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
7. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
8. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs.
KuKanich B; Papich MG
J Vet Pharmacol Ther; 2004 Aug; 27(4):239-46. PubMed ID: 15305853
[TBL] [Abstract][Full Text] [Related]
10. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
Kukanich B; Papich MG
J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
Kuroda T; Nagata S; Takizawa Y; Tamura N; Kusano K; Mizobe F; Hariu K
Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma.
Horváth V; Tolokán A; Egresi A; Pap T; Horvai G; Balogh-Nemes K; Klebovich I
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):153-9. PubMed ID: 15664345
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
Le Traon G; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
Batzias GC; Delis GA; Athanasiou LV
Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
[TBL] [Abstract][Full Text] [Related]
16. [The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs].
Hashem A; Kietzmann M; Scherkl R
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):396-8. PubMed ID: 1425314
[TBL] [Abstract][Full Text] [Related]
17. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of dirlotapide in the dog.
Merritt DA; Lynch MP; King VL
J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():24-32. PubMed ID: 17567512
[TBL] [Abstract][Full Text] [Related]
20. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
